Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 7.02M shares outstanding
USVyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets.
The company was founded in 2017 and is based in Princeton, New Jersey.
Venkateswarlu Nelabhotla
Co-Founder, Chief Executive Officer, President & Director
Robert Dickey
Chief Financial Officer
Charles G. Chavdarian
Senior Vice President of Product Development & Regulatory CMC
Jules Abraham
Investor Relations Officer
Employees
18
Country
US
Sector
Healthcare
Website
vyometx.com
Loading congressional disclosures…
based on 7.02M shares outstanding
US30d Avg
--
60d Avg
--
90d Avg
--
